Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024)
Atara Biotherapeutics' (ATRA) quarterly Inventory Average came in at $12.3 million in Q4 2024, up 51.16% on a YoY basis from $8.1 million in Q1 2024, and down 24.73% quarter-over-quarter from $16.4 million in Q3 2024.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Inventory Average (2023 - 2024) Analysis & Trends
Atara Biotherapeutics (ATRA) has reported Inventory Average for 2 consecutive years, with $12.3 million the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Inventory Average rose 51.16% year-over-year to $12.3 million; the trailing twelve-month figure through Dec 2024 stood at $12.3 million (up 51.16% YoY), and the FY2024 full-year result was $10.2 million, up 80.31% from the prior year.
- Inventory Average declined to $12.3 million in Q4 2024 per ATRA's latest filing, from $16.4 million in the prior quarter.
- Across five years, Inventory Average topped out at $17.4 million in Q2 2024 and bottomed at $3.5 million in Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 44.10 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 56.98 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 39.30 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 17.49 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 952.69 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 18.37 Mn |
| 10 | Atara Biotherapeutics | 148.00 Mn | 131.45 Mn | 439,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 12.32 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 17.42 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Dec 31, 2023 | 8.15 Mn |
| Sep 30, 2023 | 7.23 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.46 Mn |